RotationRx · Drugs · Scores · Protocols · Diagnoses · Specialties

← Drug Reference

Carbamazepine

Epilepsy, Trigeminal Neuralgia

Boxed warning

  • WARNINGS SERIOUS DERMATOLOGIC REACTIONS AND HLA-B*1502 ALLELE SERIOUS AND SOMETIMES FATAL DERMATOLOGIC REACTIONS, INCLUDING TOXIC EPIDERMAL NECROLYSIS (TEN) AND STEVENS-JOHNSON SYNDROME (SJS), HAVE BEEN REPORTED DURING TREATMENT WITH CARBAMAZEPINE. THESE REACTIONS ARE ESTIMATED TO OCCUR IN 1 TO 6 PER 10,000 NEW USERS IN COUNTRIES WITH MAINLY CAUCASIAN POPULATIONS, BUT THE RISK IN SOME ASIAN COUNTRIES IS ESTIMATED TO BE ABOUT 10 TIMES HIGHER. STUDIES IN PATIENTS OF CHINESE ANCESTRY HAVE FOUND A STRONG ASSOCIATION ... (see full label)

Indications

  • Epilepsy
  • Trigeminal Neuralgia

Adult dosing

  • epilepsy initial: dose: 200; unit: mg; route: PO; interval: twice a day (400 mg/day); fixed: true; labelExcerpt: Either 200 mg twice a day for tablets and extended-release tablets, or 1 teaspoon four times a day for suspension (400 mg/day).
  • epilepsy maintenance: dose: 800; unit: mg; route: PO; interval: daily (usually 800 to 1200 mg daily); fixed: true; labelExcerpt: Adjust dosage to the minimum effective level, usually 800 to 1200 mg daily.
  • trigeminal neuralgia initial: dose: 100; unit: mg; route: PO; interval: twice a day (total 200 mg/day); fixed: true; labelExcerpt: On the first day, either 100 mg twice a day for tablets or extended-release tablets, or ½ teaspoon four times a day for suspension, for a total daily dose of 200 mg.
  • trigeminal neuralgia maintenance: dose: 400; unit: mg; route: PO; interval: daily (usually 400 to 800 mg daily); fixed: true; labelExcerpt: Control of pain can be maintained in most patients with 400 to 800 mg daily.

Pediatric dosing

  • epilepsy under6 initial: dose: 10; unit: mg/kg/day; route: PO; interval: twice, three, or four times a day; weightBased: false; pedNote: No label-stated per-dose maximum verified; weight-based calculation disabled. Consult pharmacy/current label.; labelExcerpt: Initial 10 mg/kg/day to 20 mg/kg/day twice a day or three times a day as tablets, or four times a day as suspension.
  • epilepsy 6to12 initial: dose: 100; unit: mg; route: PO; interval: twice a day (200 mg/day); fixed: true; labelExcerpt: Either 100 mg twice a day for tablets or extended-release tablets, or ½ teaspoon four times a day for suspension (200 mg/day).
  • epilepsy over12 initial: dose: 200; unit: mg; route: PO; interval: twice a day (400 mg/day); fixed: true; labelExcerpt: Either 200 mg twice a day for tablets and extended-release tablets, or 1 teaspoon four times a day for suspension (400 mg/day).

Renal adjustment

  • Consult pharmacy/current label

Hepatic adjustment

  • Consult pharmacy/current label

Contraindications

  • Bone marrow depression
  • Hypersensitivity to carbamazepine
  • Tricyclic compound sensitivity
  • Concomitant MAO inhibitor use
  • Concomitant nefazodone use

Clinical pearls

  • Perform HLA-B*1502 screening in patients of Asian ancestry prior to initiation.
  • Obtain complete pretreatment hematological testing as a baseline.
  • Discontinue at the first sign of a rash.
  • Carbamazepine suspension should not be administered simultaneously with other liquid medications.

Source and review

  • DailyMed label (carbamazepine), Set ID 10c9795e-358c-4f6a-b7bc-cccc179617c0, effective 2026-09-23. Last reviewed: 2026-11-11